| Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan YS Chien, CP Su, HT Tsai, AS Huang, CE Lien, MN Hung, JH Chuang, ... Journal of Infection 60 (2), 168-174, 2010 | 118 | 2010 |
| Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised … SM Hsieh, MC Liu, YH Chen, WS Lee, SJ Hwang, SH Cheng, WC Ko, ... The Lancet Respiratory Medicine 9 (12), 1396-1406, 2021 | 114 | 2021 |
| CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge CE Lien, YJ Lin, C Chen, WC Lian, TY Kuo, JD Campbell, P Traquina, ... Scientific reports 11 (1), 1-7, 2021 | 47 | 2021 |
| An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled … J Torales, O Cuenca-Torres, L Barrios, L Armoa-Garcia, G Estigarribia, ... Vaccine 41 (1), 109-118, 2023 | 32 | 2023 |
| Durability and immunogenicity of neutralizing antibodies response against omicron variants after three doses of subunit SARS-CoV-2 vaccine MVC-COV1901: an extension to an open … SM Hsieh, SC Chang, HY Cheng, SR Shih, CE Lien Infectious Diseases and Therapy 11 (4), 1493-1504, 2022 | 23 | 2022 |
| An immunobridging study to evaluate the neutralizing antibody titer in adults immunized with two doses of either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901 JA Estrada, CY Cheng, SY Ku, HC Hu, HW Yeh, YC Lin, CP Chen, ... Vaccines 10 (5), 655, 2022 | 17 | 2022 |
| Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern CE Lien, TY Kuo, YJ Lin, WC Lian, MY Lin, LTC Liu, J Cheng, YC Chou, ... Clinical Infectious Diseases 74 (11), 1899-1905, 2022 | 15 | 2022 |
| A population-based cohort study on chronic comorbidity risk factors for adverse dengue outcomes CE Lien, YJ Chou, YJ Shen, T Tsai, N Huang The American journal of tropical medicine and hygiene 105 (6), 1544, 2021 | 13 | 2021 |
| Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2 KYA Huang, D Zhou, TK Tan, C Chen, HME Duyvesteyn, Y Zhao, ... Theranostics 12 (1), 1, 2022 | 9 | 2022 |
| Safety and immunogenicity of MVC-COV1901 vaccine in older adults: Phase 2 randomized dose-comparison trial A Waits, JY Chen, WH Cheng, JI Yeh, SM Hsieh, C Chen, R Janssen, ... International Journal of Infectious Diseases 124, 21-26, 2022 | 7 | 2022 |
| The reactogenicity and immunogenicity of a booster dose after the second dose of a protein subunit vaccine MVC-COV1901: an extension to an open-label, dose-escalation, and non … SM Hsieh, S Chang, HY Cheng, SR Shih, CE Lien MedRxiv, 2021.12. 01.21267115, 2021 | 7 | 2021 |
| A Phase I CE Lien, MC Liu, NC Wang, LTC Liu, CW Chung Prospective, Randomized, Open-labeled Study to Evaluate the Safety …, 2022 | 6 | 2022 |
| Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: a large-scale double-blind, randomised, placebo-controlled … H Szu-Min, MC Liu, YH Chen, WS Lee, SJ Hwang, SH Cheng, WC Ko, ... medRxiv, 2021.08. 05.21261532, 2021 | 6 | 2021 |
| Assessing the international transferability of a machine learning model for detecting medication error in the general internal medicine clinic: multicenter preliminary … YPH Chin, W Song, CE Lien, CH Yoon, WC Wang, J Liu, PA Nguyen, ... JMIR Medical Informatics 9 (1), e23454, 2021 | 6 | 2021 |
| Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial LTC Liu, CH Chiu, NC Chiu, BF Tan, CY Lin, HY Cheng, MY Lin, CE Lien, ... npj Vaccines 7 (1), 165, 2022 | 5 | 2022 |
| Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine YJ Lin, MY Lin, YS Chuang, LTC Liu, TY Kuo, C Chen, S Ganesan, ... Scientific Reports 12 (1), 11369, 2022 | 5 | 2022 |
| Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in adolescents in Taiwan: A double-blind, randomized, placebo-controlled phase 2 trial LTC Liu, CH Chiu, NC Chiu, BF Tan, CY Lin, HY Cheng, MY Lin, CE Lien, ... medRxiv, 2022.03. 14.22272325, 2022 | 5 | 2022 |
| Advanced age and increased risk for severe outcomes of dengue infection, Taiwan, 2014–2015 N Huang, YJ Shen, YJ Chou, TF Tsai, CE Lien Emerging Infectious Diseases 29 (8), 1701, 2023 | 4 | 2023 |
| Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi … L Estephan, YC Lin, YT Lin, YH Chen, SC Pan, SM Hsieh, PF Torkehagen, ... Vaccine 41 (23), 3497-3505, 2023 | 4 | 2023 |
| A retrospective study of the safety and immunogenicity of MVC-COV1901 vaccine for people living with HIV SH Cheng, CE Lien, SM Hsieh, CY Cheng, WD Liu, CL Lo, WC Ko, ... Vaccines 11 (1), 18, 2022 | 4 | 2022 |
